TEVJF Stock DD Teva Pharmaceutical Industries Ltd. 07/23/2014

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
TEVJF Teva Pharmaceutical Industries Ltd. $TEVJF Company Overview

Stock Message Board http://investorshangout.com/search?q=TEVJF&am...mp;yt1=Go!

Last Updated: 07/23/2014 16:19:52

Current Price and Quotes
Last Price 51.85
Previous Close 51.85 Open N/A
Daily Range N/A - N/A 52wk Range 38.20 - 52.26
Volume 0 Dividend N/A
Average Vol (3m) 197 Yield N/A




Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 20,314,000 20,317,000 18,312,000 16,121,000
Cost of Revenue 9,607,000 9,665,000 8,797,000 7,056,000
Gross Profit 10,707,000 10,652,000 9,515,000 9,065,000
Operating Expenses

Research and Development 1,427,000 1,356,000 1,095,000 951,000
Sales, General and Admin. 5,319,000 5,117,000 4,410,000 3,833,000
Non-Recurring Items 2,312,000 1,974,000 901,000 410,000
Other - - - -
Operating Income 1,649,000 2,205,000 3,109,000 3,871,000
Income From Continuing Operations

Add'l Income/Expense Items - - - -
Earnings Before Interest and Tax 1,649,000 2,205,000 3,109,000 3,871,000
Interest Expense 399,000 386,000 153,000 225,000
Earnings Before Tax 1,250,000 1,819,000 2,956,000 3,646,000
Income Tax (43,000) (137,000) 127,000 283,000
Minority Interest (16,000) (53,000) 9,000 8,000
Equity Earnings Unconsolidated Subsidiary (40,000) (46,000) (61,000) (24,000)
Net Income Cont. Operations 1,269,000 1,963,000 2,759,000 3,331,000
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 1,269,000 1,963,000 2,759,000 3,331,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 1,269,000 1,963,000 2,759,000 3,331,000

Recent News

Jul 23, 2014 Financial Results, Campaign Launch, and New Steps in Facility Planning - Research Reports on Johnson & Johnson, Merck, AstraZeneca, Novartis and Teva
Jul 21, 2014 Teva Completes Acquisition of Labrys: Opens Door to a Strong and Novel Migraine Prevention and Treatment Franchise within its CNS Portfolio
Jul 21, 2014 Arena Pharmaceuticals Enters into Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) in Israel
Jul 18, 2014 Teva to Report Second Quarter 2014 Financial Results on July 31, 2014
Jul 17, 2014 Health Care Sector Stocks Technical Review: Valeant Pharma, Teva Pharma Industries, Novo Nordisk, Curis, and Amarin
Jul 16, 2014 Leading U.S. Proxy Advisory Firm Supports Teva Nominees and Other Shareholders' Meeting Proposals
Jul 14, 2014 Teva Announces FDA Acceptance of NDA Filing for Investigational Short-Acting Beta-Agonist (SABA) Inhaler (Albuterol MDPI)
Jul 8, 2014 Clinical Trials, Petitions, and Upcoming Earnings Releases - Analyst Notes on Celgene, Covidien, AbbVie, Teva and Thermo Fisher Scientific
Jul 4, 2014 Teva Receives CHMP Positive Opinion for Seasonique(R) Extended-Regimen Contraceptive for Marketing Authorization in Several European Countries
Jul 3, 2014 ADDING MULTIMEDIA Teva Files Citizen Petition with the U.S. Food and Drug Administration (FDA) Regarding the Complexity of COPAXONE(R) (glatiramer acetate) Following the Agency's Guidance

1
2
3
4
5
6
next >

TEVJF Teva Pharmaceutical Industries Ltd. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=TEVJF&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/TEVJF/quote
Stock Chart http://www.otcmarkets.com/stock/TEVJF/chart
Company Info http://www.otcmarkets.com/stock/TEVJF/company-info
Recent News http://www.otcmarkets.com/stock/TEVJF/news
Financials http://www.otcmarkets.com/stock/TEVJF/financials
Filings and Disclosure http://www.otcmarkets.com/stock/TEVJF/filings
Short Sales http://www.otcmarkets.com/stock/TEVJF/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/TEVJF/insider-transactions
Research Reports http://www.otcmarkets.com/stock/TEVJF/research
Summary http://finance.yahoo.com/q?s=TEVJF
Historical Prices http://finance.yahoo.com/q/hp?s=TEVJF+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=TEVJF
Basic Chart http://finance.yahoo.com/q/bc?s=TEVJF+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=TEVJF+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=TEVJF+Headlines
Press Releases http://finance.yahoo.com/q/p?s=TEVJF+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=TEVJF+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=TEVJF+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=TEVJF+Industry
Major Holders http://finance.yahoo.com/q/mh?s=TEVJF+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=TEVJF+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=TEVJF+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=TEVJF
Balance Sheet http://finance.yahoo.com/q/bs?s=TEVJF
Cash Flow http://finance.yahoo.com/q/cf?s=TEVJF+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/TEVJF
Market Watch http://www.marketwatch.com/investing/stock/TEVJF
Bloomberg http://www.bloomberg.com/quote/TEVJF:US
Morningstar http://quotes.morningstar.com/stock/s?t=TEVJF
Bussinessweek http://investing.businessweek.com/research/st...cker=TEVJF
Barchart http://www.barchart.com/quotes/stocks/TEVJF
OTC Short Report http://otcshortreport.com/index.php?index=TEVJF
Investopedia http://www.investopedia.com/markets/stocks/TEVJF/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Introducing Pure Ionic Boron Silica Drops for Your Wellness

Updated Category News Views 98

Discover Ionic Liquid Boron Silica Drops for Optimal Wellness Smidge has recently introduced a revolutionary small-batch supplement designed to elevate your wellness routine: the Ionic Liquid Boron Silica Drops. This supplement offers essential nutrients that are often missing from even the healthiest diets. What Makes Ionic Liquid Boron Silica Drops Unique? Combining...

Continue Reading
Equity Bancshares Achieves $19.8M Net Income in Third Quarter

Updated Category News Views 96

Equity Bancshares Reports Impressive Q3 Results Equity Bancshares, Inc. (NASDAQ: EQBK) has announced a net income of $19.8 million, translating to $1.28 per diluted share, for the third quarter of 2024. Notably, the adjusted net income, which accommodates the merger expenses from the KansasLand transaction, stands at $20.2 million or $1.31 per diluted share. Key...

Continue Reading
ASM International Announces Key Nominations for Board

Updated Category News Views 296

ASM Nomination Overview The Supervisory Board of ASM International N.V. today announced key nominations aimed at strengthening the leadership structure of the company. This decision reflects the board's commitment to maintaining continuity and leveraging the vast experience of its members. Reappointment of Paul Verhagen as CFO Paul Verhagen is proposed for reappointment...

Continue Reading
China's Commitment to Ecological Development in Global Context

Updated Category News Views 326

China's Green Transition Commitment During a significant annual meeting, China reaffirmed its commitment to advancing ecological civilization and improving global environmental governance. This event showcased China's dedication to promoting sustainability on an international level, highlighting contributions from numerous experts and leaders. Key Takeaways from the...

Continue Reading
Elliott Advocates for Change at Sumitomo Realty & Development

Updated Category News Views 171

Elliott's Influence in Sumitomo Realty's Decision-Making Elliott Investment Management, L.P. and Elliott Advisors (UK) Limited hold significant influence as one of the largest shareholders in Sumitomo Realty & Development Co., Ltd. with over 3% ownership. This ownership stake provides Elliott a platform to advocate for strategic changes within the company, especially...

Continue Reading